InsidersTradesSigma
Follow the 恒瑞医药 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 恒瑞医药 has logged 2 insider filings. Market capitalisation: €354.8bn. The latest transaction was reported on 2 September 2025 (Sale). Among the most active insiders: 孙杰平. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
恒瑞医药是一家中国公司，专注于医疗保健和制药领域。该公司在上海证券交易所 (XSHG) 上市。